Literature DB >> 21743324

Generalized immune activation and innate immune responses in simian immunodeficiency virus infection.

Steven E Bosinger1, Donald L Sodora, Guido Silvestri.   

Abstract

PURPOSE OF REVIEW: Chronic immune activation is a key factor driving the immunopathogenesis of AIDS. During pathogenic HIV/simian immunodeficiency virus (SIV) infections, innate and adaptive antiviral immune responses contribute to chronic immune activation. In contrast, nonpathogenic SIV infections of natural hosts such as sooty mangabeys and African green monkeys (AGMs) are characterized by low immune activation despite similarly high viremia. This review focuses on the role of innate immune responses in SIV infection. RECENT
FINDINGS: Several studies have examined the role of innate immune responses to SIV as potential drivers of immune activation. The key result of these studies is that both pathogenic SIV infection of macaques and nonpathogenic SIV infections of natural hosts are associated with strong innate immune responses to the virus, high production of type I interferons by plasmacytoid dendritic cells, and upregulation of interferon-stimulated genes (ISGs). However, SIV-infected sooty mangabeys and AGMs (but not SIV-infected macaques) rapidly downmodulate the interferon response within 4-6 weeks of infection, thus resulting in a state of limited immune activation during chronic infection.
SUMMARY: Studies in nonhuman primates suggest that chronic innate/interferon responses may contribute to AIDS pathogenesis. Further, the ability of natural host species to resolve innate immune responses after infection provides a novel avenue for potential immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21743324      PMCID: PMC3261611          DOI: 10.1097/COH.0b013e3283499cf6

Source DB:  PubMed          Journal:  Curr Opin HIV AIDS        ISSN: 1746-630X            Impact factor:   4.283


  56 in total

1.  HIV-activated human plasmacytoid DCs induce Tregs through an indoleamine 2,3-dioxygenase-dependent mechanism.

Authors:  Olivier Manches; David Munn; Anahita Fallahi; Jeffrey Lifson; Laurence Chaperot; Joel Plumas; Nina Bhardwaj
Journal:  J Clin Invest       Date:  2008-10       Impact factor: 14.808

Review 2.  Toward an AIDS vaccine: lessons from natural simian immunodeficiency virus infections of African nonhuman primate hosts.

Authors:  Donald L Sodora; Jonathan S Allan; Cristian Apetrei; Jason M Brenchley; Daniel C Douek; James G Else; Jacob D Estes; Beatrice H Hahn; Vanessa M Hirsch; Amitinder Kaur; Frank Kirchhoff; Michaela Muller-Trutwin; Ivona Pandrea; Jörn E Schmitz; Guido Silvestri
Journal:  Nat Med       Date:  2009-08       Impact factor: 53.440

3.  Evidence of dysregulation of dendritic cells in primary HIV infection.

Authors:  Rachel Lubong Sabado; Meagan O'Brien; Abhignya Subedi; Li Qin; Nan Hu; Elizabeth Taylor; Oliver Dibben; Andrea Stacey; Jacques Fellay; Kevin V Shianna; Frederick Siegal; Michael Shodell; Kokila Shah; Marie Larsson; Jeffrey Lifson; Arthur Nadas; Michael Marmor; Richard Hutt; David Margolis; Donald Garmon; Martin Markowitz; Fred Valentine; Persephone Borrow; Nina Bhardwaj
Journal:  Blood       Date:  2010-08-06       Impact factor: 22.113

4.  Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia.

Authors:  Guido Silvestri; Donald L Sodora; Richard A Koup; Mirko Paiardini; Shawn P O'Neil; Harold M McClure; Silvija I Staprans; Mark B Feinberg
Journal:  Immunity       Date:  2003-03       Impact factor: 31.745

5.  Nonpathogenic SIV infection of African green monkeys induces a strong but rapidly controlled type I IFN response.

Authors:  Béatrice Jacquelin; Véronique Mayau; Brice Targat; Anne-Sophie Liovat; Désirée Kunkel; Gaël Petitjean; Marie-Agnès Dillies; Pierre Roques; Cécile Butor; Guido Silvestri; Luis D Giavedoni; Pierre Lebon; Françoise Barré-Sinoussi; Arndt Benecke; Michaela C Müller-Trutwin
Journal:  J Clin Invest       Date:  2009-12       Impact factor: 14.808

6.  HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-alpha.

Authors:  Andrew W Hardy; David R Graham; Gene M Shearer; Jean-Philippe Herbeuval
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-23       Impact factor: 11.205

7.  The relationship between simian immunodeficiency virus RNA levels and the mRNA levels of alpha/beta interferons (IFN-alpha/beta) and IFN-alpha/beta-inducible Mx in lymphoid tissues of rhesus macaques during acute and chronic infection.

Authors:  Kristina Abel; Michelle J Alegria-Hartman; Kristina Rothaeusler; Marta Marthas; Christopher J Miller
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Distinct cycling CD4(+)- and CD8(+)-T-cell profiles during the asymptomatic phase of simian immunodeficiency virus SIVmac251 infection in rhesus macaques.

Authors:  V Monceaux; R Ho Tsong Fang; M C Cumont; B Hurtrel; J Estaquier
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 9.  Lessons learned from the natural hosts of HIV-related viruses.

Authors:  Mirko Paiardini; Ivona Pandrea; Cristian Apetrei; Guido Silvestri
Journal:  Annu Rev Med       Date:  2009       Impact factor: 13.739

10.  Disparate effects of acute and chronic infection with SIVmac239 or SHIV-89.6P on macaque plasmacytoid dendritic cells.

Authors:  R Keith Reeves; Patricia N Fultz
Journal:  Virology       Date:  2007-05-08       Impact factor: 3.616

View more
  38 in total

1.  The well-tempered SIV infection: Pathogenesis of SIV infection in natural hosts in the wild, with emphasis on virus transmission and early events post-infection that may contribute to protection from disease progression.

Authors:  Kevin Raehtz; Ivona Pandrea; Cristian Apetrei
Journal:  Infect Genet Evol       Date:  2016-07-06       Impact factor: 3.342

2.  A single amino acid mutation in the envelope cytoplasmic tail restores the ability of an attenuated simian immunodeficiency virus mutant to deplete mucosal CD4+ T cells.

Authors:  Matthew W Breed; Andrea P O Jordan; Pyone P Aye; Chie Sugimoto; Xavier Alvarez; Marcelo J Kuroda; Bapi Pahar; Brandon F Keele; James A Hoxie; Andrew A Lackner
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

Review 3.  Improving genome assemblies and annotations for nonhuman primates.

Authors:  Robert B Norgren
Journal:  ILAR J       Date:  2013

Review 4.  Double-negative T cells during HIV/SIV infections: potential pinch hitters in the T-cell lineup.

Authors:  Vasudha Sundaravaradan; Kiran D Mir; Donald L Sodora
Journal:  Curr Opin HIV AIDS       Date:  2012-03       Impact factor: 4.283

5.  Physiologic changes in a nonhuman primate model of HIV-associated pulmonary arterial hypertension.

Authors:  M Patricia George; Hunter C Champion; Marc Simon; Siobhan Guyach; Rebecca Tarantelli; Heather M Kling; Alexandra Brower; Christopher Janssen; Jessica Murphy; Jonathan P Carney; Alison Morris; Mark T Gladwin; Karen A Norris
Journal:  Am J Respir Cell Mol Biol       Date:  2012-12-13       Impact factor: 6.914

Review 6.  Simian immunodeficiency virus interactions with macaque dendritic cells.

Authors:  Natalia Teleshova; Nina Derby; Elena Martinelli; Pavel Pugach; Giulia Calenda; Melissa Robbiani
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

7.  Mucosal priming with a replicating-vaccinia virus-based vaccine elicits protective immunity to simian immunodeficiency virus challenge in rhesus monkeys.

Authors:  Caijun Sun; Zhiwei Chen; Xian Tang; Yinfeng Zhang; Liqiang Feng; Yanhua Du; Lijun Xiao; Li Liu; Weijun Zhu; Ling Chen; Linqi Zhang
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

8.  Loss of a tyrosine-dependent trafficking motif in the simian immunodeficiency virus envelope cytoplasmic tail spares mucosal CD4 cells but does not prevent disease progression.

Authors:  Matthew W Breed; Andrea P O Jordan; Pyone P Aye; Cornelis F Lichtveld; Cecily C Midkiff; Faith R Schiro; Beth S Haggarty; Chie Sugimoto; Xavier Alvarez; Netanya G Sandler; Daniel C Douek; Marcelo J Kuroda; Bapi Pahar; Michael Piatak; Jeffrey D Lifson; Brandon F Keele; James A Hoxie; Andrew A Lackner
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

Review 9.  Immune activation and HIV persistence: implications for curative approaches to HIV infection.

Authors:  Nichole R Klatt; Nicolas Chomont; Daniel C Douek; Steven G Deeks
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

Review 10.  Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs.

Authors:  Eleanor M P Wilson; Irini Sereti
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.